Pediatric sepsis

Brittany Mathias1, Juan C Mira, Shawn D Larson

  • 1Department of Surgery, University of Florida College of Medicine, Gainesville, Florida, USA.

Insights

Pediatric sepsis, a leading cause of child death, requires distinct management from adults. Protocol implementation is crucial for improving diagnosis, treatment adherence, and patient outcomes in children.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Clinical research

Background:

  • Sepsis is the primary cause of mortality in children globally.
  • Annual US hospitalizations for pediatric sepsis exceed 72,000, with a 25% mortality rate and $4.8 billion economic burden.
  • Recognition of pediatric sepsis as distinct from adult sepsis is a recent development.

Purpose of the Study:

  • To review the evolving definition and management of pediatric sepsis.
  • To highlight the challenges in applying research findings to clinical practice due to definitional discrepancies.
  • To emphasize the importance of timely diagnosis and adherence to treatment guidelines for improved pediatric sepsis outcomes.

Main Methods:

  • Review of current literature on pediatric sepsis definitions and management.
  • Analysis of the disconnect between clinical and research definitions.
  • Evaluation of the impact of protocolized care on sepsis outcomes.

Main Results:

  • The definition of pediatric sepsis is evolving, creating a gap between research and clinical practice.
  • Speed of diagnosis and timely guideline implementation are key to improving outcomes.
  • Low adherence to current guidelines necessitates protocol implementation for better care.

Conclusions:

  • Pediatric sepsis management requires adaptation distinct from adult protocols due to unique physiology.
  • Prospective pediatric trials are needed to tailor management strategies.
  • Widespread adoption of protocolized care pathways is essential for improving pediatric sepsis care and outcomes.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
369
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
322
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
443
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
678
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
720
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
618